The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALBEMARLE CORP | 7.25% DEP SHS A | 012653200 | 6,300,000 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | |||
| ALBERTSONS COS INC | COMMON STOCK | 013091103 | 13,860,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
| ALBERTSONS COS INC | COMMON STOCK | 013091103 | 9,702,000 | 525,000 | SH | Call | SOLE | 525,000 | 0 | 0 | ||
| ALTICE USA INC | CL A | 02156K103 | 3,075,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | |||
| BAUSCH HEALTH COS INC | COM | 071734107 | 3,672,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
| EQUINOX GOLD CORP | COM | 29446Y502 | 609,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| IHS HOLDING LIMITED | ORD SHS | G4701H109 | 2,990,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| INTEL CORP | COM | 458140100 | 11,730,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| PARAMOUNT GLOBAL | CLASS B COM | 92556H206 | 37,170,000 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | |||
| SANA BIOTECHNOLOGY INC | COM | 799566104 | 416,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| WARNER BROS DISCOVERY INC | COM SER A | 934423104 | 12,375,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| WARNER BROS DISCOVERY INC | COM SER A | 934423104 | 13,200,000 | 1,600,000 | SH | Call | SOLE | 1,600,000 | 0 | 0 | ||